dc.creatorCamargo, Rodrigo Pauperio Soares de
dc.creatorSimões, José Antonio
dc.creatorCecatti, José Guilherme
dc.creatorAlves, Valéria Moraes Nader
dc.creatorFaro, Sebastian
dc.date2005-May
dc.date2015-11-27T13:02:16Z
dc.date2015-11-27T13:02:16Z
dc.date.accessioned2018-03-29T01:01:08Z
dc.date.available2018-03-29T01:01:08Z
dc.identifierSão Paulo Medical Journal = Revista Paulista De Medicina. v. 123, n. 3, p. 108-12, 2005-May.
dc.identifier1516-3180
dc.identifier/S1516-31802005000300004
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/16021272
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/196336
dc.identifier16021272
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1296569
dc.descriptionBacterial vaginosis has been associated with prematurity and other perinatal complications. However, the efficacy of the treatment for preventing such complications has not yet been well established. The objective of this study was to evaluate the impact of treatment for bacterial vaginosis on a low-risk population of Brazilian pregnant women, in order to prevent prematurity and other perinatal complications. Observational retrospective cohort study, at the Obstetric and Gynecology Department, Universidade Estadual de Campinas (Unicamp). Vaginal bacterioscopy results from 785 low-risk pregnant women were studied. Three different groups of women were identified: 580 without bacterial vaginosis during pregnancy, 134 with bacterial vaginosis treated using imidazoles (metronidazole, tinidazole, or secnidazole) during pregnancy, and 71 with bacterial vaginosis not treated during pregnancy. The diagnosis of bacterial vaginosis was based on Nugent's criteria, from the vaginal bacterioscopy performed during the first prenatal care visit. The frequency of prematurity was 5.5% among the women without bacterial vaginosis, 22.5% among those with untreated bacterial vaginosis and 3.7% among those with treated bacterial vaginosis. The risk ratios for perinatal complications were significantly higher in the group with untreated bacterial vaginosis: premature rupture of membranes, 7.5 (95% CI: 1.9-34.9); preterm labor, 3.4 (95% CI: 1.4-8.1); preterm birth, 6.0 (95% CI: 1.9-19.7); and low birth weight, 4.2 (95% CI: 1.2-14.3). The treatment of bacterial vaginosis significantly reduced the rates of prematurity and other perinatal complications among these low-risk Brazilian pregnant women, regardless of the history of previous preterm delivery.
dc.description123
dc.description108-12
dc.languageeng
dc.relationSão Paulo Medical Journal = Revista Paulista De Medicina
dc.relationSao Paulo Med J
dc.rightsaberto
dc.rights
dc.sourcePubMed
dc.subjectAdult
dc.subjectCohort Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectImidazoles
dc.subjectInfant, Newborn
dc.subjectLogistic Models
dc.subjectObstetric Labor, Premature
dc.subjectPregnancy
dc.subjectPregnancy Complications, Infectious
dc.subjectPregnancy Outcome
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectVaginosis, Bacterial
dc.titleImpact Of Treatment For Bacterial Vaginosis On Prematurity Among Brazilian Pregnant Women: A Retrospective Cohort Study.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución